92 related articles for article (PubMed ID: 33271340)
21. Application of Akaike information criterion to evaluate warfarin dosing algorithm.
Harada T; Ariyoshi N; Shimura H; Sato Y; Yokoyama I; Takahashi K; Yamagata S; Imamaki M; Kobayashi Y; Ishii I; Miyazaki M; Kitada M
Thromb Res; 2010 Sep; 126(3):183-90. PubMed ID: 20553802
[TBL] [Abstract][Full Text] [Related]
22. Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans.
Steiner HE; Giles JB; Patterson HK; Feng J; El Rouby N; Claudio K; Marcatto LR; Tavares LC; Galvez JM; Calderon-Ospina CA; Sun X; Hutz MH; Scott SA; Cavallari LH; Fonseca-Mendoza DJ; Duconge J; Botton MR; Santos PCJL; Karnes JH
Front Pharmacol; 2021; 12():749786. PubMed ID: 34776967
[TBL] [Abstract][Full Text] [Related]
23. Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients.
Perini JA; Struchiner CJ; Silva-Assunção E; Santana IS; Rangel F; Ojopi EB; Dias-Neto E; Suarez-Kurtz G
Clin Pharmacol Ther; 2008 Dec; 84(6):722-8. PubMed ID: 18754001
[TBL] [Abstract][Full Text] [Related]
25. An Ensemble Model With Clustering Assumption for Warfarin Dose Prediction in Chinese Patients.
Tao Y; Chen YJ; Xue L; Xie C; Jiang B; Zhang Y
IEEE J Biomed Health Inform; 2019 Nov; 23(6):2642-2654. PubMed ID: 30624235
[TBL] [Abstract][Full Text] [Related]
26. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.
Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C
OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300
[TBL] [Abstract][Full Text] [Related]
27. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Anderson JL; Horne BD; Stevens SM; Woller SC; Samuelson KM; Mansfield JW; Robinson M; Barton S; Brunisholz K; Mower CP; Huntinghouse JA; Rollo JS; Siler D; Bair TL; Knight S; Muhlestein JB; Carlquist JF
Circulation; 2012 Apr; 125(16):1997-2005. PubMed ID: 22431865
[TBL] [Abstract][Full Text] [Related]
28. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
29. Genotype-guided dosing of warfarin through modeling and simulation.
Deng J; Vozmediano V; Rodriguez M; Cavallari LH; Schmidt S
Eur J Pharm Sci; 2017 Nov; 109S():S9-S14. PubMed ID: 28502675
[TBL] [Abstract][Full Text] [Related]
30. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
van Schie RM; Wadelius MI; Kamali F; Daly AK; Manolopoulos VG; de Boer A; Barallon R; Verhoef TI; Kirchheiner J; Haschke-Becher E; Briz M; Rosendaal FR; Redekop WK; Pirmohamed M; Maitland van der Zee AH
Pharmacogenomics; 2009 Oct; 10(10):1687-95. PubMed ID: 19842940
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
[TBL] [Abstract][Full Text] [Related]
33. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
34. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.
Sconce EA; Khan TI; Wynne HA; Avery P; Monkhouse L; King BP; Wood P; Kesteven P; Daly AK; Kamali F
Blood; 2005 Oct; 106(7):2329-33. PubMed ID: 15947090
[TBL] [Abstract][Full Text] [Related]
35. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events.
Karaca S; Bozkurt NC; Cesuroglu T; Karaca M; Bozkurt M; Eskioglu E; Polimanti R
Pharmacogenomics; 2015; 16(10):1109-18. PubMed ID: 26216670
[TBL] [Abstract][Full Text] [Related]
36. Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data.
Roche-Lima A; Roman-Santiago A; Feliu-Maldonado R; Rodriguez-Maldonado J; Nieves-Rodriguez BG; Carrasquillo-Carrion K; Ramos CM; da Luz Sant'Ana I; Massey SE; Duconge J
Front Pharmacol; 2019; 10():1550. PubMed ID: 32038238
[TBL] [Abstract][Full Text] [Related]
37. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.
Gage BF; Eby C; Milligan PE; Banet GA; Duncan JR; McLeod HL
Thromb Haemost; 2004 Jan; 91(1):87-94. PubMed ID: 14691573
[TBL] [Abstract][Full Text] [Related]
38. Warfarin Pharmacogenetics: New Life for an Old Drug.
Wen MS; Lee MT
Acta Cardiol Sin; 2013 May; 29(3):235-42. PubMed ID: 27122712
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.
Xie C; Xue L; Zhang Y; Zhu J; Zhou L; Hang Y; Ding X; Jiang B; Miao L
Pharmacogenomics; 2020 Jan; 21(1):23-32. PubMed ID: 31849278
[No Abstract] [Full Text] [Related]
40. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
Arwood MJ; Deng J; Drozda K; Pugach O; Nutescu EA; Schmidt S; Duarte JD; Cavallari LH
Clin Pharmacol Ther; 2017 May; 101(5):675-683. PubMed ID: 28032893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
